Long term tenofovir disoproxil fumarate (TDF) therapy and the risk of hepatocellular carcinoma

被引：0
|
作者：
Sievert, W. [1 ,2 ]
Strasser, S. [3 ]
Gane, E. [4 ]
George, J. [5 ]
Weilert, F. [6 ]
Flaherty, J. F. [7 ]
Dinh, P. [7 ]
Schall, R. A. [7 ]
Martins, E. B. [7 ]
Yee, L. [7 ]
Marcellin, P. [8 ]
Kim, W. R. [9 ]
机构：
[1] Monash Univ, Melbourne, Vic 3004, Australia
[2] Monash Med Ctr, Melbourne, Vic, Australia
[3] Royal Prince Alfred Hosp, Sydney, NSW, Australia
[4] Auckland City Hosp, Auckland, New Zealand
[5] Univ Sydney, Westmead Hosp, Storr Liver Unit, Sydney, NSW 2006, Australia
[6] Waikato Hosp, Hamilton, New Zealand
[7] Gilead Sci Inc, Foster City, CA 94404 USA
[8] Hop Beaujon, Clichy, France
[9] Mayo Clin, Rochester, MN USA
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2013年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：53 / 54
页数：2
相关论文
共 50 条
  • [41] Tenofovir disoproxil fumarate (TDF) is highly active for treatment of chronic hepatitis B in subjects with cirrhosis
    Wang, Chia
    Buti, Maria
    Hadziyannis, Stephanos J.
    Mathurin, Philipe
    Sherman, Morris
    Strasser, Simone I.
    Petersen, Joerg
    Tong, Myron J.
    Sorbel, Jeff
    Mondou, Elsa
    Anderson, Jane
    Rousseau, Franck
    GASTROENTEROLOGY, 2008, 134 (04) : A808 - A809
  • [42] Efficacy and Safety of Tenofovir Alafenamide (TAF) at 96 Weeks in Chronic HBV (CHB) Patients with Risk Factors for Use of Tenofovir Disoproxil Fumarate (TDF)
    Buti, Maria
    Stepanova, Tatjana
    Celen, Mustafa K.
    Flisiak, Robert
    Ryder, Stephen D.
    Streinu-Cercel, Adrian
    Gurel, Selim
    Flaherty, John F.
    Gaggar, Anuj
    Suri, Vithika
    Mo, Shuyuan
    Subramanian, Mani
    Nurmukhametova, Elena
    Zoulim, Fabien
    Andreone, Pietro
    Marcellin, Patrick
    HEPATOLOGY, 2017, 66 : 488A - 488A
  • [43] Tenofovir disoproxil fumarate (TDF) is highly active for treatment of chronic hepatitis B in subjects with cirrhosis
    Butil, M.
    Hadziyannis, S.
    Mathurin, P.
    Urbanek, P.
    Sherman, M.
    Strasser, S.
    Wang, C.
    Petersen, J.
    Sorbel, J.
    Mondou, E.
    Anderson, J.
    Rousseau, F.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S33 - S33
  • [44] No evidence of drug resistance mutations in a seroconverter exposed to tenofovir disoproxil fumarate (TDF) chemoprophylaxis in Africa
    Atchison, R. E.
    Peterson, L.
    Clark, E.
    Liegler, T. J.
    Cates, W.
    Grant, R. M.
    ANTIVIRAL THERAPY, 2007, 12 : S97 - S97
  • [45] Tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) switches: real-world observation of impact on lipid profiles
    Banks, T.
    Ashton, K.
    Ustianowski, A.
    Uriel, A.
    HIV MEDICINE, 2020, 21 : 56 - 57
  • [46] Adherence Measurements of Post-use Tenofovir Disoproxil Fumarate (TDF) and Tenofovir/Levonorgestrel (TFV/LNG) Intravaginal Rings
    Qiu, Jiang
    Su, Jonathan T.
    Sung, Samuel
    Clark, Meredith R.
    Kiser, Patrick Franklin
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2016, 32 : 217 - 217
  • [47] The Effect of Switching from Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF) on Liver Enzymes, Glucose, and Lipid Profile
    Squillace, Nicola
    Ricci, Elena
    Menzaghi, Barbara
    De Socio, Giuseppe Vittorio
    Passerini, Simone
    Martinelli, Canio
    Mameli, Maria Sabrina
    Maggi, Paolo
    Falasca, Katia
    Cordier, Laura
    Celesia, Benedetto Maurizio
    Salomoni, Elena
    Di Biagio, Antonio
    Pellicano, Giovanni Francesco
    Bonfanti, Paolo
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2020, 14 : 5515 - 5520
  • [48] Atherosclerotic CVD risk profile of tenofovir alafenamide versus tenofovir disoproxil fumarate
    Huhn, G.
    Shamblaw, D.
    Baril, J. G.
    Baker, D.
    Ward, D.
    Guo, S.
    Haubrich, R.
    Nguyen-Cleary, T.
    McCallister, S.
    Das, M.
    ANTIVIRAL THERAPY, 2016, 21 : A45 - A45
  • [49] Tenofovir disoproxil fumarate on the risk of hepatocellular carcinoma in chronic hepatitis B patients with failure to preceding treatments: A nationwide cohort study
    Lee, Jayoun
    Kim, Gi-Ae
    Kim, Hyo Jeong
    Cho, Songhee
    Ko, Min Jung
    Lim, Young-Suk
    JOURNAL OF VIRAL HEPATITIS, 2021, 28 (08) : 1150 - 1159
  • [50] Tenofovir disoproxil fumarate reduces hepatocellular carcinoma, decompensation and death in chronic hepatitis B patients with cirrhosis
    Liu, Ken
    Choi, Jonggi
    Le, An
    Yip, Terry Cheuk-Fung
    Wong, Vincent Wai-Sun
    Chan, Stephen Lam
    Chan, Henry Lik-Yuen
    Nguyen, Mindie H.
    Lim, Young-Suk
    Wong, Grace Lai-Hung
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 50 (09) : 1037 - 1048
12345